19 January 2018
Australian-made test makes doctor’s and patient’s life “a whole lot easier”
Mycoplasma genitalium is a little-known sexually transmitted infection affecting up to two per cent of the population. A new test...
7 December 2017
Aussie ‘Nobel’ spotlights SpeeDx war on superbug
Cicada Innovations, a “super incubator”, and headquarters for the SpeeDx office, manufacturing and production facilities, have created an event to...
6 December 2017
SpeeDx Pty. Ltd. establishes US-based operation
SpeeDx Pty. Ltd. announced the incorporation of a US-based subsidiary company, SpeeDx Inc. The US base will support current clinical...
21 November 2017
Antibiotic-resistant Mycoplasma genitalium may soon be as great a health risk as chlamydia
According to health professionals, Mycoplasma genitalium is developing resistance to antibiotics at an alarming rate. Much like chlamydia, many people...
10 November 2017
SpeeDx is transforming global health outcomes
SpeeDx has significantly contributed to the success and development of the Australian MedTech industry. The CSIRO’s Medical Technologies and Pharmaceutical...
8 November 2017
Elisa Mokany – winner of the “Outstanding Achievement” Medtech Industry award
We are happy to announce our Chief Technology Officer, Elisa Mokany, has won the "Outstanding Achievement" award at the Medical...
